Aurora Cannabis (TSX: ACB) (NYSE: ACB) announced that they will be reporting their fiscal third quarter financials after market close on March 13th. Analysts have a consensus C$12.58 12-month price target on the company, via a total of 13 analysts, with seven analysts having hold ratings, four analysts having sell ratings and two analysts having strong sell ratings. The street high comes from Bryan Garnier with a C$20 price target, and the lowest target comes from Stifel with a C$7.80 price target.
Twelve analysts have revenue estimates for the third quarter. The mean between all 12 is C$68.94 million; this number has been revised downwards from C$75.24 million at the start of the year. Piper Sandler currently has the highest revenue estimate with C$74.50 million, while the lowest comes from Stifel with a C$60 million estimate.
Only five analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 43.90%, with this number being revised downwards from 47.55% at the start of the year. Street high goes to Cantor Fitzgerald with a 53% estimate and the lowest sits at 31.50%
Onto EBITDA estimates, there are currently 10 analysts who have third quarter EBITDA estimates. The mean is currently (C$10.30) million, with this number being down from C$1.76 million at the start of the year. Street high goes to MKM Partners with a $0 million EBITDA estimate and the lowest being from Needham & Co with a (C$13.61) million estimate.
Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
The Skeptical Investor’s Guide to Reading a Corporate Press Release
“I just read it, right? Why do I need a guide?” – You, likely, after...